Medicare Enrolled
Dr. Scott McGee, MD
Hematology & Oncology · Massillon, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. McGee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McGee?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McGee
Dr. Scott McGee is a hematology & oncology specialist in Massillon, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. McGee performed 144,187 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. McGee received a total of $21,675 from 108 pharmaceutical and/or device companies across 1228 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McGee is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 2% volume in OH
$21,675 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗144,187
Medicare services
Top 2% in OH for hematology & oncology
Not available
Unique patients (not deduplicated)
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
88,500 | $1 | $3 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
8,954 | $0 | $1 |
| Injection, granisetron, extended-release, 0.1 mg | 8,900 | $5 | $10 |
| Denosumab injection (Prolia/Xgeva) | 8,220 | $18 | $37 |
| Paclitaxel chemotherapy injection | 7,632 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 7,000 | $43 | $103 |
| Anti-nausea injection (aprepitant) | 3,640 | $1 | $5 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,770 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,719 | $8 | $19 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,656 | $8 | $15 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
479 | $11 | $30 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
478 | $10 | $33 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
467 | $59 | $133 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
457 | $94 | $170 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
375 | $86 | $216 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
363 | $96 | $206 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
270 | $2 | $20 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
230 | $22 | $51 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
216 | $13 | $25 |
| Iron level test | 215 | $6 | $24 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
214 | $9 | $37 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
178 | $12 | $39 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
154 | $6 | $19 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
141 | $0 | $1 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
138 | $6 | $26 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
136 | $47 | $104 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
126 | $1 | $5 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
125 | $54 | $105 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
122 | $1 | $6 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
107 | $9 | $29 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
105 | $48 | $102 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
97 | $1 | $5 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
93 | $24 | $74 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
88 | $4 | $22 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
70 | $135 | $234 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
62 | $15 | $26 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
62 | $28 | $75 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
62 | $17 | $48 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
61 | $21 | $55 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
53 | $2 | $5 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
50 | $118 | $233 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
49 | $131 | $247 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
47 | $16 | $40 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
46 | $16 | $46 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
40 | $40 | $82 |
| New patient office visit, complex (60-74 min) | 38 | $167 | $292 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
36 | $61 | $134 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
30 | $29 | $51 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
30 | $14 | $25 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
26 | $62 | $136 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
22 | $8 | $15 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
21 | $71 | $70 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
17 | $56 | $106 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
62.2% high complexity
33.3% medium
4.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$21,675
Total received (2018-2024)
Avg $3,096/year across 7 years
Top 19% in OH for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
108
Companies
1,228
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,724
2023
$4,334
2022
$3,432
2021
$1,994
2020
$1,632
2019
$3,222
2018
$3,335
Payments by company (2024)
PFIZER INC.
$316
Merck Sharp & Dohme LLC
$241
Daiichi Sankyo Inc.
$235
Janssen Biotech, Inc.
$220
Novartis Pharmaceuticals Corporation
$216
AstraZeneca Pharmaceuticals LP
$204
Eisai Inc.
$154
Astellas Pharma US Inc
$151
E.R. Squibb & Sons, L.L.C.
$133
Lilly USA, LLC
$93
ABBVIE INC.
$91
Takeda Pharmaceuticals U.S.A., Inc.
$89
Incyte Corporation
$85
Bayer Healthcare Pharmaceuticals Inc.
$79
Stemline Therapeutics Inc.
$77
Genentech USA, Inc.
$74
PharmaEssentia USA Corporation
$68
Celgene Corporation
$61
PUMA BIOTECHNOLOGY, INC.
$54
Amneal Pharmaceuticals LLC
$54
Agios Pharmaceuticals, Inc.
$49
Genmab U.S., Inc.
$48
JAZZ PHARMACEUTICALS INC.
$48
Ipsen Biopharmaceuticals, Inc
$47
Boehringer Ingelheim Pharmaceuticals, Inc.
$41
Aveo Pharmaceuticals, Inc.
$40
ADC Therapeutics America, Inc.
$40
SOBI, INC
$39
Alexion Pharmaceuticals, Inc.
$38
SERVIER PHARMACEUTICALS LLC
$37
GlaxoSmithKline, LLC.
$37
Iovance Biotherapeutics, Inc.
$36
ARRAY BIOPHARMA INC
$36
TAIHO ONCOLOGY, INC.
$36
Karyopharm Therapeutics Inc.
$34
Regeneron Healthcare Solutions, Inc.
$32
Mirati Therapeutics, Inc.
$31
Exelixis Inc.
$30
Coherus Biosciences Inc.
$29
Blueprint Medicines Corporation
$27
Biocon Biologics Inc
$25
Legend Biotech USA Inc.
$22
EMD Serono, Inc.
$21
MorphoSys, US Inc.
$21
Tempus AI, Inc
$21
Organon Llc
$20
SpringWorks Therapeutics, Inc.
$20
Fresenius Kabi USA, LLC
$20
Deciphera Pharmaceuticals Inc.
$20
Sumitomo Pharma America, Inc.
$19
Gilead Sciences, Inc.
$18
Spectrum Pharmaceuticals Inc.
$17
Pharmacosmos Therapeutics Inc.
$15
GENZYME CORPORATION
$15
Top 3 companies account for 21.3% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,405
Novartis Pharmaceuticals Corporation
$1,358
AstraZeneca Pharmaceuticals LP
$1,095
E.R. Squibb & Sons, L.L.C.
$1,059
Celgene Corporation
$987
Genentech USA, Inc.
$986
Janssen Biotech, Inc.
$838
Merck Sharp & Dohme LLC
$828
Astellas Pharma US Inc
$648
Daiichi Sankyo Inc.
$636
Incyte Corporation
$617
PFIZER INC.
$578
Merck Sharp & Dohme Corporation
$530
Lilly USA, LLC
$515
Takeda Pharmaceuticals U.S.A., Inc.
$497
Eisai Inc.
$485
Boehringer Ingelheim Pharmaceuticals, Inc.
$351
Pharmacyclics LLC, An AbbVie Company
$320
Bayer HealthCare Pharmaceuticals Inc.
$319
GENZYME CORPORATION
$302
EISAI INC.
$275
Ipsen Biopharmaceuticals, Inc
$250
Seagen Inc.
$244
Puma Biotechnology, Inc.
$237
PUMA BIOTECHNOLOGY, INC.
$222
AMAG Pharmaceuticals, Inc.
$212
TESARO, Inc.
$203
GlaxoSmithKline, LLC.
$195
Regeneron Healthcare Solutions, Inc.
$194
EMD Serono, Inc.
$192
Pharmacyclics LLC, an AbbVie Company
$183
Agios Pharmaceuticals, Inc.
$173
Bayer Healthcare Pharmaceuticals Inc.
$173
ABBVIE INC.
$168
Myriad Genetic Laboratories, Inc.
$162
AbbVie, Inc.
$154
SOBI, INC
$154
Janssen Pharmaceuticals, Inc
$151
Gilead Sciences, Inc.
$150
Stemline Therapeutics Inc.
$133
G1 Therapeutics, Inc.
$123
Exelixis Inc.
$121
Coherus Biosciences Inc.
$116
JAZZ PHARMACEUTICALS INC.
$109
Karyopharm Therapeutics Inc.
$109
Genmab U.S., Inc.
$108
BeiGene USA, Inc.
$104
ARRAY BIOPHARMA INC
$103
Dova Pharmaceuticals
$101
Alexion Pharmaceuticals, Inc.
$94
AVEO Pharmaceuticals, Inc.
$93
Blueprint Medicines Corporation
$92
PharmaEssentia USA Corporation
$90
NOVARTIS PHARMACEUTICALS CORPORATION
$87
Servier Pharmaceuticals LLC
$86
Kite Pharma, Inc.
$85
Taiho Oncology, Inc.
$74
Foundation Medicine, Inc.
$71
ADC Therapeutics America, Inc.
$69
Sumitomo Pharma America, Inc.
$67
MorphoSys, US Inc.
$64
TAIHO ONCOLOGY, INC.
$64
Dendreon Pharmaceuticals LLC
$60
Rigel Pharmaceuticals, Inc.
$58
Pharmacosmos Therapeutics Inc.
$57
Deciphera Pharmaceuticals Inc.
$57
SERVIER PHARMACEUTICALS LLC
$56
Amneal Pharmaceuticals LLC
$54
Advanced Accelerator Applications
$53
Teva Pharmaceuticals USA, Inc.
$53
AbbVie Inc.
$50
Jazz Pharmaceuticals Inc.
$49
Apellis Pharmaceuticals, Inc.
$48
Mirati Therapeutics, Inc.
$45
TerSera Therapeutics LLC
$42
Aveo Pharmaceuticals, Inc.
$40
Myovant Sciences Inc.
$40
Seattle Genetics, Inc.
$39
Iovance Biotherapeutics, Inc.
$36
Mylan Institutional Inc.
$36
Epizyme, Inc.,
$34
Kyowa Kirin, Inc.
$32
Clovis Oncology, Inc.
$31
Helsinn Therapeutics (U.S.), Inc.
$30
Sobi, Inc
$30
Progenics Pharmaceuticals, Inc.
$27
Heron Therapeutics, Inc.
$26
Biocon Biologics Inc
$25
Organon LLC
$25
MEDIVATION FIELD SOLUTIONS LLC
$23
Legend Biotech USA Inc.
$22
EUSA Pharma (US) LLC
$22
Sun Pharmaceutical Industries Inc.
$22
Tempus AI, Inc
$21
Organon Llc
$20
Catalyst Pharmaceuticals, Inc.
$20
SpringWorks Therapeutics, Inc.
$20
Fresenius Kabi USA, LLC
$20
MACROGENICS, INC.
$19
Adaptive Biotechnologies Corporation
$18
Spectrum Pharmaceuticals Inc.
$17
Otsuka America Pharmaceutical, Inc.
$17
ImmunoGen, Inc.
$15
Mylan Pharmaceuticals Inc.
$13
Octapharma USA, Inc.
$12
Lexicon Pharmaceuticals, Inc.
$12
Acceleron Pharma, Inc.
$12
SUN PHARMACEUTICAL INDUSTRIES INC.
$12
Top 3 companies account for 17.8% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · AVASTIN · AVSOLA · AYVAKIT · Alecensa · Aliqopa · Amtagvi · Avastin · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · CREON · CYRAMZA · Cabometyx · Cinvanti · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELZONRIS · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · EVENITY · EXKIVITY · Elahere · Empaveli · Enhertu · Epkinly · Erleada · FASLODEX · FERAHEME · FIRDAPSE · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Fulphila · GAZYVA · GILOTRIF · HEMLIBRA · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Itovebi · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LOQTORZI · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MARGENZA · MEKINIST · MONJUVI · MYRISK · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM · OGSIVEO · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Ogivri · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · PYLARIFY · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RETACRIT · RETEVMO · ROLVEDON · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rituxan Hycela · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · Somatuline Depot · Stimufend · Stivarga · Sylvant · TABRECTA · TAFINLAR · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tibsovo · Tivdak · Trodelvy · Turalio · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYNDAQEL · VYXEOS · Vanflyta · Vectibix · Venclexta · Vitrakvi · Voranigo · Vyloy · WAINUA · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZIIHERA · ZOLADEX · ZYKADIA · ZYTIGA · clonoSEQ · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
30
County median income
$65,740
Nearest hospital to ZIP centroid (approximate)
MERCY MEDICAL CENTER
3.2 mi
3.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. McGee is a mixed practice specialist, with above-average Medicare volume (top 2% in OH), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. McGee experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. McGee performed 88,500 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. McGee receive payments from pharmaceutical companies?
Yes. Dr. McGee received a total of $21,675 from 108 companies across 1,228 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McGee's costs compare to other hematology & oncology specialists in Massillon?
Dr. McGee's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McGee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Massillon
Browse hematology & oncology specialists in Massillon ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in OH
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in OH
Which OH hematology & oncology specialists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology